Cibc World Market Inc. Makes New Investment in Smith & Nephew SNATS, Inc. $SNN

Cibc World Market Inc. bought a new stake in shares of Smith & Nephew SNATS, Inc. (NYSE:SNN) during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The fund bought 33,153 shares of the medical equipment provider’s stock, valued at approximately $2,079,000.

A number of other large investors also recently made changes to their positions in SNN. BlackRock Inc. purchased a new stake in shares of Smith & Nephew SNATS in the second quarter worth approximately $505,323,000. River Road Asset Management LLC grew its position in Smith & Nephew SNATS by 13.8% during the fourth quarter. River Road Asset Management LLC now owns 3,169,644 shares of the medical equipment provider’s stock valued at $103,996,000 after purchasing an additional 384,926 shares in the last quarter. Goldman Sachs Group Inc. grew its position in Smith & Nephew SNATS by 5.2% during the fourth quarter. Goldman Sachs Group Inc. now owns 2,053,726 shares of the medical equipment provider’s stock valued at $67,383,000 after purchasing an additional 100,697 shares in the last quarter. Bank of New York Mellon Corp acquired a new position in Smith & Nephew SNATS in the 2nd quarter valued at approximately $89,325,000. Finally, Dimensional Fund Advisors LP increased its stake in Smith & Nephew SNATS by 44.5% in the 1st quarter. Dimensional Fund Advisors LP now owns 1,052,747 shares of the medical equipment provider’s stock valued at $33,436,000 after buying an additional 324,080 shares during the period. Institutional investors and hedge funds own 25.64% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities research analysts have issued reports on the stock. Canaccord Genuity Group cut their target price on shares of Smith & Nephew SNATS from $32.00 to $30.00 and set a “hold” rating for the company in a research report on Monday, May 11th. Wall Street Zen raised shares of Smith & Nephew SNATS from a “hold” rating to a “buy” rating in a research note on Monday. Sanford C. Bernstein set a $31.85 price objective on Smith & Nephew SNATS in a report on Monday, May 11th. Barclays cut Smith & Nephew SNATS from an “equal weight” rating to an “underweight” rating in a research report on Wednesday, August 5th. Finally, Weiss Ratings downgraded Smith & Nephew SNATS from a “hold (c+)” rating to a “hold (c)” rating in a research note on Thursday, June 11th. Two investment analysts have rated the stock with a Buy rating, six have given a Hold rating and two have given a Sell rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus target price of $30.93.

Smith & Nephew SNATS Stock Performance

NYSE:SNN opened at $29.32 on Thursday. Smith & Nephew SNATS, Inc. has a 12 month low of $28.56 and a 12 month high of $38.79. The company has a debt-to-equity ratio of 0.62, a current ratio of 2.14 and a quick ratio of 1.11. The company’s 50 day moving average is $30.26 and its 200-day moving average is $31.74.

Smith & Nephew SNATS Announces Dividend

The company also recently announced a dividend, which will be paid on Friday, November 6th. Investors of record on Friday, October 2nd will be paid a $0.312 dividend. The ex-dividend date is Friday, October 2nd. This represents a yield of 205.0%.

Smith & Nephew SNATS Company Profile

Smith & Nephew plc is a global medical technology company specializing in the design, development and manufacture of advanced surgical devices, orthopaedic reconstruction implants, trauma and extremities products, sports medicine solutions and wound care therapies. Founded in 1856 in Hull, United Kingdom, the company has grown through both organic innovation and strategic acquisitions to offer a broad portfolio that addresses patient needs across joint replacement, minimally invasive surgery and wound healing.

In its orthopaedics business, Smith & Nephew provides hip and knee replacement systems, modular joint revision implants and biologic solutions for bone repair.